PAG
MTNB icon

Private Advisor Group’s Matinas BioPharma MTNB Stock Holding History

Private Advisor Group’s Portfolio MTNB Stock Details MTNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-6,941
Closed -$54.9K – 2481
2024
Q2 		$54.9K Hold
6,941
– – ﹤0.01% 2267
2024
Q1 		$94K Buy
6,941
+194
+3% +$2.31K ﹤0.01% 2206
2023
Q4 		$72.9K Buy
6,747
+1,600
+31% +$18.1K ﹤0.01% 2144
2023
Q3 		$33.5K Buy
5,147
+841
+20% +$10.3K ﹤0.01% 2064
2023
Q2 		$77K Buy
4,306
+400
+10% +$9.33K ﹤0.01% 1945
2023
Q1 		$91.8K Buy
3,906
+100
+3% +$2.53K ﹤0.01% 1874
2022
Q4 		$25K Buy
3,806
+396
+12% +$13.2K ﹤0.01% 953
2022
Q3 		$109K Sell
3,410
-1,200
-26% -$47.1K ﹤0.01% 1768
2022
Q2 		$181K Sell
4,610
-180
-4% -$6.86K ﹤0.01% 1864
2022
Q1 		$192K Buy
4,790
+1,791
+60% +$65.9K ﹤0.01% 1909
2021
Q4 		$151K Sell
2,999
-1,420
-32% -$75.9K ﹤0.01% 1977
2021
Q3 		$288K Buy
4,419
+2,046
+86% +$88.3K ﹤0.01% 1718
2021
Q2 		$92K Sell
2,373
-352
-13% -$15.1K ﹤0.01% 1909
2021
Q1 		$143K Buy
2,725
+427
+19% +$28.6K ﹤0.01% 1782
2020
Q4 		$156K Sell
2,298
-449
-16% -$20.8K ﹤0.01% 1661
2020
Q3 		$106K Hold
2,747
– – ﹤0.01% 1486
2020
Q2 		$107K Buy
2,747
+615
+29% +$23.6K ﹤0.01% 1667
2020
Q1 		$64K Buy
2,132
+765
+56% +$46.2K ﹤0.01% 1355
2019
Q4 		$154K Sell
1,367
-134
-9% -$7.76K ﹤0.01% 1527
2019
Q3 		$50K Buy
1,501
+300
+25% +$10.8K ﹤0.01% 1607
2019
Q2 		$51K Buy
1,201
+194
+19% +$9.32K ﹤0.01% 1624
2019
Q1 		$55K Buy
1,007
+10
+1% +$539 ﹤0.01% 1513
2018
Q4 		$30K Buy
997
+500
+101% +$19.6K ﹤0.01% 1338
2018
Q3 		$23K Buy
+497
New +$10.7K ﹤0.01% 1578
2018
Q2 		– Sell
-350
Closed -$13K – 1391
2018
Q1 		$13K Buy
+350
New +$18.5K ﹤0.01% 1143

Other funds holding MTNB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
HCM
Highbridge Capital Management New York $3.09B AUM 31.19% 1-Year Est. Return
SIG
Sargent Investment Group Bethesda, Maryland $759M AUM 28.58% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $18.5B AUM 23.32% 1-Year Est. Return

Private Advisor Group's MTNB Position: Q3 2024 in Review

Private Advisor Group sold out of Matinas BioPharma (MTNB) in Q3 2024, closing a stake of 6,941 shares — an estimated $54.9K sold.

Private Advisor Group first reported a position in MTNB in Q1 2018 and held it in 25 quarters. The position peaked at $288K in Q3 2021. 18 funds tracked by Wall St. Rank hold MTNB as of Q3 2024.

  • Private Advisor Group reported no remaining Matinas BioPharma position as of Q3 2024 after selling out during the quarter.
  • Private Advisor Group sold 6,941 Matinas BioPharma shares in Q3 2024, an estimated $54.9K.
  • Private Advisor Group first reported a position in Matinas BioPharma in Q1 2018 and held it in 25 quarters.
  • Private Advisor Group's Matinas BioPharma position peaked at $288K in Q3 2021.
  • 18 funds tracked by Wall St. Rank held Matinas BioPharma as of Q3 2024.

Based on Private Advisor Group's 13F filing for Q3 2024, filed 22 Oct 2024.